about
The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeuticsAdjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationElevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer CellsEndogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.Follicular helper T cells in rheumatoid arthritis.A lack of Fas/FasL signalling leads to disturbances in the antiviral response during ectromelia virus infection.Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity.The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy.An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.PD-L1 expression in tumor tissue and peripheral blood of patients with oral squamous cell carcinoma.Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer.PD-L1/B7-H1 Inhibits Viral Clearance by Macrophages in HSV-1-Infected Corneas.Enhanced IL-6/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper/T follicular regulatory cells in patients with rheumatoid arthritis
P2860
Q26738677-988AB314-10F5-477E-8321-D6E49D292B5AQ28074536-E52544A9-A519-4BDE-ADF5-68F31706CA81Q37303319-5246849C-2263-4927-9333-BE50A0AA5F74Q37501812-545F909C-628F-4A8A-96C4-4169038E010AQ38557816-FF4330B9-31B6-4287-BE0E-DD7419773FA9Q38802297-5CBF7A6E-F3BB-49B1-A6EC-67BB03FAD7D6Q39163678-CB6CE793-8B7F-47A5-AF61-5EC97AD078A9Q39400469-62BAF323-D3F5-407F-B8DA-1E044A92FFA7Q47602259-4C71AC59-B5D7-4256-93F8-5B19B999D657Q49713164-C27DF429-E177-4B1D-A913-A8E252BDA9C8Q51218209-263E3FB0-49AA-4B22-8CCA-21A22D89E257Q51369795-0B88C7FA-035A-4CE1-9A9F-A41418C17D29Q52564388-E9A12525-FC37-4A98-BBB5-0F2B4071D294Q52737068-77772885-2532-46AC-B115-3C13777090EEQ54233022-A135D44A-2A3A-49F1-8B87-FC7672AFD884Q58695077-8AF173B8-6325-44E4-9FAE-F920B99F0438
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
PD-1 as an immune modulatory receptor.
@ast
PD-1 as an immune modulatory receptor.
@en
type
label
PD-1 as an immune modulatory receptor.
@ast
PD-1 as an immune modulatory receptor.
@en
prefLabel
PD-1 as an immune modulatory receptor.
@ast
PD-1 as an immune modulatory receptor.
@en
P2860
P1433
P1476
PD-1 as an immune modulatory receptor
@en
P2093
P2860
P304
P356
10.1097/PPO.0000000000000060
P50
P577
2014-07-01T00:00:00Z